We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00992693
Recruitment Status : Enrolling by invitation
First Posted : October 9, 2009
Last Update Posted : October 12, 2017
Sponsor:
Collaborator:
Valeant Pharmaceuticals International, Inc.
Information provided by (Responsible Party):
U.S. Army Medical Research and Materiel Command

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Primary Completion Date : July 19, 2016
  Estimated Study Completion Date : January 2018